Integrated Wealth Concepts’s Nuvation Bio NUVB Stock Holding History
Bought
Maintained
Sold
Other funds holding NUVB
DC
VCM
OFM
LCM
DFO
Integrated Wealth Concepts's NUVB Position: Q1 2026 in Review
Integrated Wealth Concepts increased its Nuvation Bio (NUVB) stake by 17% in Q1 2026, buying an estimated $20.1K and bringing the position to 24,856 shares worth $107K. The position accounts for ﹤0.01% of the portfolio, ranked #2172.
Integrated Wealth Concepts first reported a position in NUVB in Q2 2025 and has held it in 4 quarters since. The position peaked at $190K in Q4 2025. 231 funds tracked by Wall St. Rank hold NUVB as of Q1 2026.
- Integrated Wealth Concepts held 24,856 shares of Nuvation Bio worth $107K as of Q1 2026.
- Integrated Wealth Concepts bought 3,616 Nuvation Bio shares in Q1 2026, an estimated $20.1K.
- Nuvation Bio made up ﹤0.01% of Integrated Wealth Concepts's portfolio in Q1 2026, its #2172 holding.
- Integrated Wealth Concepts first reported a position in Nuvation Bio in Q2 2025 and has held it in 4 quarters since.
- Integrated Wealth Concepts's Nuvation Bio position peaked at $190K in Q4 2025.
- 231 funds tracked by Wall St. Rank held Nuvation Bio as of Q1 2026.
Based on Integrated Wealth Concepts's 13F filing for Q1 2026, filed 15 May 2026.